Amneal Pharmaceuticals

(NASDAQ) AMRX

Current Price$12.81

Market Cap$4.08B

Since IPO (2018)-15%

5 Year+132%

1 Year+65%

1 Month+7%

Amneal Pharmaceuticals Financials at a Glance

Market Cap

$4.08B

Revenue (TTM)

$2.32B

Net Income (TTM)

$44.12M

EPS (TTM)

$0.37

P/E Ratio

34.25

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$12.81

Volume

13,601

Open

$12.77

Price

$12.81

Volume

13,601

Open

$12.77

Previous Close

$12.80

Daily Range

$12.77 - $12.99

52-Week Range

$7.02 - $15.42

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$12.81

Volume

13,601

Open

$12.77

Previous Close

$12.80

Daily Range

$12.77 - $12.99

52-Week Range

$7.02 - $15.42

AMRX News

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares?

Robert IzquierdoNov 28, 2025

Top Drug Stocks Under $5

David HaenMar 26, 2020

Amneal Ramping Up Malaria Drug Production to Treat Coronavirus Patients

Mark PrvulovicMar 20, 2020

Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19?

Brian Orelli, PhDMar 20, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amneal Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

8,500

CEO

Chintu Patel, PhD; Chirag K. Patel, PhD

Website

www.amneal.com

Headquarters

Bridgewater, NJ 08807, US

AMRX Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

10%

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

2.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.08B

Shares Outstanding

319.00M

Volume

13.60K

Avg. Volume

2.01M

Financials (TTM)

Gross Profit

$1.14B

Operating Income

$423.09M

EBITDA

$603.87M

Operating Cash Flow

$339.99M

Capital Expenditure

$70.06M

Free Cash Flow

$269.93M

Cash & ST Invst.

$310.87M

Total Debt

$2.74B

Amneal Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.08B

N/A

Market Cap/Employee

$491.95K

N/A

Employees

8,300

N/A

Net Income

$15.74M

-229.1%

EBITDA

$0.00

-100.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$2.43B

+2.2%

Accounts Receivable

$939.87M

+21.2%

Inventory

$606.30M

-1.0%

Long Term Debt

$2.71B

+20.5%

Short Term Debt

$21.58M

-93.7%

Return on Assets

1.20%

N/A

Return on Invested Capital

8.07%

N/A

Free Cash Flow

$87.15M

-8.3%

Operating Cash Flow

$130.31M

+10.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NVSTEnvista Holdings Corp

NVSTEnvista Holdings Corp$25.67-0.89%

INDVIndivior Pharmaceuticals Inc

INDVIndivior Pharmaceuticals Inc$35.24+3.19%

TLXTelix Pharmaceuticals Limited

TLXTelix Pharmaceuticals Limited$10.84+3.93%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$95.66+1.55%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$17.68+1.58%

SUPNSupernus Pharmaceuticals, Inc.

SUPNSupernus Pharmaceuticals, Inc.$48.30-0.50%

LNTHLantheus Holdings, Inc.

LNTHLantheus Holdings, Inc.$82.90+2.13%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.46+0.00%

MARAMara Holdings

MARAMara Holdings$12.21+0.14%

FFord Motor Company

FFord Motor Company$11.88-0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.51+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.37+0.04%

HCAIHuachen Ai Parking Management Technology

HCAIHuachen Ai Parking Management Technology$11.30+1.07%

HTZHertz Global

HTZHertz Global$6.83+0.22%

Questions About AMRX

What is the current price of Amneal Pharmaceuticals?

Amneal Pharmaceuticals is trading at $12.82 per share.

What is the 52-week range for Amneal Pharmaceuticals?

Over the past 52 weeks, Amneal Pharmaceuticals has traded between $7.02 and $15.42.

How much debt does Amneal Pharmaceuticals have?

As of the most recent reporting period, Amneal Pharmaceuticals reported total debt of $2.69B.

How much cash does Amneal Pharmaceuticals have on hand?

Amneal Pharmaceuticals reported $197.66M in cash and cash equivalents in its most recent financial results.

What is Amneal Pharmaceuticals’s dividend yield?

Amneal Pharmaceuticals does not currently have a dividend yield.

Amneal Pharmaceuticals

Amneal Pharmaceuticals Financials at a Glance

AMRX News

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares?

Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs

Amneal (AMRX) Q2 EPS Jumps 56%

Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday

FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet

Top Drug Stocks Under $5

Amneal Ramping Up Malaria Drug Production to Treat Coronavirus Patients

Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Amneal Pharmaceuticals

AMRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Amneal Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AMRX

What is the current price of Amneal Pharmaceuticals?

What is the 52-week range for Amneal Pharmaceuticals?

How much debt does Amneal Pharmaceuticals have?

How much cash does Amneal Pharmaceuticals have on hand?

What is Amneal Pharmaceuticals’s dividend yield?

Premium Investing Services